|
US3121076A
(en)
|
|
1964-02-11 |
|
Benzodiazepinones and processes |
|
US3109843A
(en)
|
|
1963-11-05 |
|
Process for preparing |
|
GB235187A
(en)
|
1924-06-07 |
1926-06-03 |
Robert Howe Gould |
Improvements in burglar and like alarms
|
|
US1873732A
(en)
|
1928-12-28 |
1932-08-23 |
Abbott Lab |
Bactericide applicable to acid-fast bacteria
|
|
US3136815A
(en)
|
1959-12-10 |
1964-06-09 |
Hoffmann La Roche |
Amino substituted benzophenone oximes and derivatives thereof
|
|
US3371085A
(en)
|
1959-12-10 |
1968-02-27 |
Hoffmann La Roche |
5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
|
|
US3116203A
(en)
|
1962-03-14 |
1963-12-31 |
Hoffmann La Roche |
Oleaginous systems
|
|
NL298071A
(https=)
|
1963-06-04 |
|
|
|
|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
|
CH427803A
(de)
|
1963-12-06 |
1967-01-15 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Isoxazolderivates
|
|
US3397209A
(en)
|
1966-11-25 |
1968-08-13 |
Geigy Chem Corp |
3-hydroxy-5-isoxazole-carboxamide
|
|
US3885046A
(en)
|
1969-12-04 |
1975-05-20 |
Burroughs Wellcome Co |
Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression
|
|
BE759838A
(fr)
|
1969-12-04 |
1971-06-03 |
Wellcome Found |
Cetones a activite biologique
|
|
FR2077918B1
(https=)
|
1970-02-24 |
1973-04-06 |
Berthier Laboratoires |
|
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
|
US3821249A
(en)
|
1970-03-13 |
1974-06-28 |
En Nom Collectif Science Union |
Dibenzothiazefin derivatives
|
|
US3819631A
(en)
|
1970-12-15 |
1974-06-25 |
May & Baker Ltd |
Azapurinones
|
|
OA04285A
(fr)
|
1972-01-07 |
1979-12-31 |
Rhone Poulenc Sa |
Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
|
|
USRE31617E
(en)
|
1972-02-04 |
1984-06-26 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US3932407A
(en)
|
1973-11-19 |
1976-01-13 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
|
US4036840A
(en)
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
|
GB1457873A
(en)
|
1973-01-04 |
1976-12-08 |
Allen & Hanburys Ltd |
Imidazotriazines
|
|
US4051236A
(en)
|
1973-02-15 |
1977-09-27 |
E. R. Squibb & Sons, Inc. |
Inhibition of blood platelet aggregation
|
|
US4280957A
(en)
|
1974-09-11 |
1981-07-28 |
Hoffmann-La Roche Inc. |
Imidazodiazepines and processes therefor
|
|
AR208414A1
(es)
|
1974-11-07 |
1976-12-27 |
Rhone Poulenc Ind |
Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
|
|
US4093617A
(en)
|
1974-11-12 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US3960927A
(en)
|
1975-03-18 |
1976-06-01 |
Richardson-Merrell Inc. |
Olefinic derivatives of amino acids
|
|
FR2319338A1
(fr)
|
1975-08-01 |
1977-02-25 |
Synthelabo |
Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent
|
|
YU96177A
(en)
|
1976-04-24 |
1982-08-31 |
Wuelfing Johann A |
Process for obtaining adenine derivatives
|
|
US4067971A
(en)
*
|
1976-05-13 |
1978-01-10 |
The Procter & Gamble Company |
Therapeutic composition
|
|
USRE30511E
(en)
|
1977-02-03 |
1981-02-10 |
American Cyanamid Company |
Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
|
|
US4107307A
(en)
|
1977-02-03 |
1978-08-15 |
American Cyanamid Company |
Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
|
|
US4404380A
(en)
|
1977-02-14 |
1983-09-13 |
Mead Johnson & Company |
Triazolopyrimidines
|
|
CA1095906A
(en)
|
1977-02-14 |
1981-02-17 |
Davis L. Temple, Jr. |
Heterocyclopyrimidines, compositions and therapeutic process
|
|
US4107309A
(en)
|
1977-05-23 |
1978-08-15 |
American Cyanamid Company |
Substituted imidazo[1,2-d]-as-triazines
|
|
US4096257A
(en)
|
1977-05-23 |
1978-06-20 |
American Cyanamid Company |
Substituted imidazo [1,2-d]-as-triazines
|
|
IN148482B
(https=)
|
1977-06-03 |
1981-03-07 |
Pfizer |
|
|
DK270378A
(da)
|
1977-06-20 |
1978-12-21 |
Krogsgaard Larsen P |
Isoxazolderivater
|
|
US4370328A
(en)
|
1977-11-03 |
1983-01-25 |
Pfizer Inc. |
Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
|
|
CA1086735A
(en)
|
1977-11-03 |
1980-09-30 |
John C. Danilewicz |
Piperidino-quinazolines
|
|
US4146718A
(en)
|
1978-04-10 |
1979-03-27 |
Bristol-Myers Company |
Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
|
|
US4366156A
(en)
|
1979-03-05 |
1982-12-28 |
Mead Johnson & Company |
Antiallergic methods using diazaheterocyclopurines
|
|
CA1143728A
(en)
|
1979-10-04 |
1983-03-29 |
Max Gerecke |
Imidazodiazepine derivatives
|
|
JPS5668695A
(en)
|
1979-11-10 |
1981-06-09 |
Sankyo Co Ltd |
Enzyme inhibitor griseolic acid and its preparation
|
|
US4642345A
(en)
|
1980-08-14 |
1987-02-10 |
Mead Johnson & Company |
6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones
|
|
US4301176A
(en)
|
1980-08-18 |
1981-11-17 |
Warner-Lambert Company |
Method of administering calcium valproate
|
|
US4361583A
(en)
|
1980-08-19 |
1982-11-30 |
Synthelabo |
Analgesic agent
|
|
FR2492258A1
(fr)
|
1980-10-17 |
1982-04-23 |
Pharmindustrie |
Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
|
|
FR2492382A1
(fr)
|
1980-10-22 |
1982-04-23 |
Synthelabo |
Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
|
|
US4489078A
(en)
|
1980-11-24 |
1984-12-18 |
Mead Johnson & Company |
Diazaheterocyclopurines used as anti-broncho spasmatics and vasodilators
|
|
US4383999A
(en)
|
1981-05-26 |
1983-05-17 |
Smithkline Beckman Corporation |
Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
|
|
LU83729A1
(fr)
|
1981-11-04 |
1983-09-01 |
Galephar |
Sels d'acide valproique,leur preparation et leur utilisation
|
|
US4513135A
(en)
|
1982-03-05 |
1985-04-23 |
Eli Lilly And Company |
Diaryl-pyrazine derivatives affecting GABA binding
|
|
CH655110A5
(de)
|
1982-09-03 |
1986-03-27 |
Otsuka Pharma Co Ltd |
Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
|
|
US4663320A
(en)
|
1983-02-16 |
1987-05-05 |
Syntex (U.S.A.) Inc. |
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
|
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
|
US4900836A
(en)
|
1983-06-23 |
1990-02-13 |
American Cyanamid Company |
(3-amino-1H-pyrazol-4-yl) (aryl)methanones
|
|
US4521422A
(en)
|
1983-06-23 |
1985-06-04 |
American Cyanamid Company |
Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
|
US4626538A
(en)
|
1983-06-23 |
1986-12-02 |
American Cyanamid Company |
[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
|
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
|
US4593029A
(en)
|
1984-02-15 |
1986-06-03 |
Syntex (U.S.A.) Inc. |
Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
|
|
GB8425872D0
(en)
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
|
DK288385D0
(da)
|
1985-06-26 |
1985-06-26 |
Novo Industri As |
Aminosyrederivater
|
|
ES2031821T3
(es)
|
1985-10-17 |
1993-01-01 |
Smith Kline & French Laboratories Limited |
Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo.
|
|
US4670434A
(en)
|
1985-11-14 |
1987-06-02 |
Syntex (U.S.A.) Inc. |
(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
|
|
JPH073631B2
(ja)
*
|
1986-02-05 |
1995-01-18 |
ミノルタ株式会社 |
フォントカートリッジとそのデータ管理方法
|
|
US4775674A
(en)
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
|
FR2600650B1
(fr)
|
1986-06-27 |
1988-09-09 |
Synthelabo |
Procede de preparation d'imidazopyridines et composes intermediaires
|
|
ES2061502T3
(es)
*
|
1986-06-27 |
1994-12-16 |
Beecham Group Plc |
Nuevos n-heterociclos biciclicos puenteados.
|
|
GB8615785D0
(en)
|
1986-06-27 |
1986-08-06 |
Beecham Group Plc |
Compounds
|
|
US4701459A
(en)
|
1986-07-08 |
1987-10-20 |
Bristol-Myers Company |
7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
|
|
US4761416A
(en)
|
1986-07-25 |
1988-08-02 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
|
|
US4739056A
(en)
|
1986-11-26 |
1988-04-19 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl)oxy-alkylamides and related compounds
|
|
US4710508A
(en)
*
|
1986-12-08 |
1987-12-01 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
|
US4786648A
(en)
*
|
1986-12-08 |
1988-11-22 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
|
US4766118A
(en)
|
1986-12-22 |
1988-08-23 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical use
|
|
US5081242A
(en)
|
1986-12-22 |
1992-01-14 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones
|
|
US4721784A
(en)
|
1986-12-22 |
1988-01-26 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones
|
|
US4992457A
(en)
|
1987-03-18 |
1991-02-12 |
Schulman Jerome M |
Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
|
|
AU614513B2
(en)
|
1987-04-15 |
1991-09-05 |
Beecham Group Plc |
1-azabicyclic compounds
|
|
GB8714789D0
(en)
|
1987-06-24 |
1987-07-29 |
Lundbeck & Co As H |
Heterocyclic compounds
|
|
US4981858A
(en)
|
1987-08-13 |
1991-01-01 |
State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research |
Optical isomers
|
|
US5319115A
(en)
|
1987-08-25 |
1994-06-07 |
Cocensys Inc. |
Method for making 3α-hydroxy, 3β-substituted-pregnanes
|
|
USRE35517E
(en)
|
1987-08-25 |
1997-05-20 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
US5120723A
(en)
|
1987-08-25 |
1992-06-09 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5412096A
(en)
|
1987-10-05 |
1995-05-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrochloride salts of heterocyclic spiro compounds
|
|
DE3853758T2
(de)
|
1987-10-05 |
1995-09-07 |
Yamanouchi Pharma Co Ltd |
Heterozyklische Spiroverbindungen und ihre Herstellung.
|
|
IL88156A
(en)
|
1987-11-13 |
1997-02-18 |
Novo Nordisk As |
Azacyclic compounds their preparation and pharmaceutical compositions containing them
|
|
EP0322182A3
(en)
|
1987-12-22 |
1992-01-02 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
|
FR2625201B1
(fr)
*
|
1987-12-24 |
1990-06-15 |
Sanofi Sa |
Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
|
|
US5091431A
(en)
|
1988-02-08 |
1992-02-25 |
Schering Corporation |
Phosphodiesterase inhibitors
|
|
DK177889A
(da)
*
|
1988-04-15 |
1989-10-16 |
Beecham Group Plc |
Hidtil ukendte forbindelser
|
|
GB8820266D0
(en)
|
1988-08-26 |
1988-09-28 |
Smith Kline French Lab |
Compounds
|
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
|
CA2000041A1
(en)
|
1988-10-13 |
1990-04-13 |
Barry S. Orlek |
Compounds
|
|
DE8817121U1
(de)
|
1988-11-22 |
1993-02-04 |
Boehringer Ingelheim Kg, 55218 Ingelheim |
Neue Quinuclidine
|
|
US5286864A
(en)
|
1988-11-22 |
1994-02-15 |
Boehringer Ingelheim Kg |
Quinuclidines, their use as medicaments and processes for their preparation
|
|
FR2663326B2
(fr)
|
1989-11-17 |
1992-10-16 |
Sanofi Sa |
Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
|
|
US5043345A
(en)
*
|
1989-02-22 |
1991-08-27 |
Novo Nordisk A/S |
Piperidine compounds and their preparation and use
|
|
US4971972A
(en)
|
1989-03-23 |
1990-11-20 |
Schering Corporation |
Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
|
|
US5278170A
(en)
|
1989-04-13 |
1994-01-11 |
Beecham Group P.L.C. |
Azabicylo oxime compounds
|
|
SG48315A1
(en)
|
1989-04-13 |
1998-04-17 |
Beecham Group Plc |
Novel compounds
|
|
DE69026197T2
(de)
|
1989-10-07 |
1997-01-09 |
Beecham Group Plc |
Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
|
US5010086A
(en)
|
1990-02-28 |
1991-04-23 |
Sterling Drug Inc. |
Imidazopyridines, compositions and use
|
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
|
GB9005737D0
(en)
|
1990-03-14 |
1990-05-09 |
Beecham Group Plc |
Novel compounds
|
|
US5407938A
(en)
*
|
1990-04-10 |
1995-04-18 |
Israel Institute For Biological Research |
Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
|
|
US5534520A
(en)
|
1990-04-10 |
1996-07-09 |
Fisher; Abraham |
Spiro compounds containing five-membered rings
|
|
US5852029A
(en)
|
1990-04-10 |
1998-12-22 |
Israel Institute For Biological Research |
Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
|
|
US5229382A
(en)
*
|
1990-04-25 |
1993-07-20 |
Lilly Industries Limited |
2-methyl-thieno-benzodiazepine
|
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
|
US5095015A
(en)
|
1990-07-24 |
1992-03-10 |
Neurogen Corporation |
Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
|
|
FR2663934B1
(fr)
|
1990-06-27 |
1994-06-03 |
Adir |
Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
|
|
DK198590D0
(da)
|
1990-08-21 |
1990-08-21 |
Novo Nordisk As |
Heterocykliske forbindelser, deres fremstilling og anvendelse
|
|
US5527813A
(en)
*
|
1990-08-21 |
1996-06-18 |
Novo Nordisk A/S |
Heterocyclic compounds and their preparation and use
|
|
US5376668A
(en)
|
1990-08-21 |
1994-12-27 |
Novo Nordisk A/S |
Heterocyclic compounds
|
|
MX9100779A
(es)
|
1990-08-24 |
1992-04-01 |
Beecham Group Plc |
Compuestos azabiciclicos y procedimiento para su preparacion
|
|
CA2050264A1
(en)
|
1990-08-30 |
1992-03-01 |
Raymond Baker |
Substituted pyrazine and its salts, compositions containing them and their use in medicine
|
|
GB9019095D0
(en)
|
1990-09-01 |
1990-10-17 |
Beecham Group Plc |
Novel compounds
|
|
US5185446A
(en)
|
1990-09-04 |
1993-02-09 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands
|
|
EP0738717A1
(en)
|
1990-10-09 |
1996-10-23 |
Neurogen Corporation |
Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines
|
|
EP0552213A1
(en)
|
1990-10-12 |
1993-07-28 |
Beecham Group Plc |
1,2,5,6-tetrahydropyridine oxime derivatives
|
|
EP0481262B1
(en)
|
1990-10-15 |
1995-02-15 |
Societe Des Produits Nestle S.A. |
Treatment of black tea
|
|
US5139802A
(en)
|
1990-10-15 |
1992-08-18 |
Nestec S.A. |
Oxidation of tea
|
|
US5744602A
(en)
|
1990-10-31 |
1998-04-28 |
Neurogen Corporation |
Certain imidazoquinoxalines; a new class of GABA brain receptor ligands
|
|
US6268496B1
(en)
|
1990-10-31 |
2001-07-31 |
Neurogen Corporation |
Certain imidazoquinoxalines: a new class of GABA brain receptor ligands
|
|
US5130430A
(en)
|
1990-10-31 |
1992-07-14 |
Neurogen Corporation |
2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
|
|
US5116837A
(en)
|
1990-12-21 |
1992-05-26 |
Ortho Pharmaceutical Corporation |
2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
|
|
US5137895A
(en)
|
1991-04-29 |
1992-08-11 |
A. H. Robins Company, Incorporated |
3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols
|
|
US5093333A
(en)
|
1991-04-29 |
1992-03-03 |
American Home Products Corporation |
N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system
|
|
US5124460A
(en)
|
1991-05-06 |
1992-06-23 |
Merck Sharp & Dohme Ltd. |
Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes
|
|
EP0590150B1
(en)
|
1991-05-15 |
1998-07-08 |
Yamanouchi Pharmaceutical Co. Ltd. |
(-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate
|
|
US5641791A
(en)
|
1991-08-13 |
1997-06-24 |
Novo Nordisk A.S |
Heterocyclic compounds and their preparation and use
|
|
US5182386A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
|
|
US5182290A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain oxazoloquinolinones; a new class of GABA brain receptor ligands
|
|
EP0603312A4
(en)
|
1991-09-13 |
1995-06-07 |
Cocensys Inc |
NEW GABA A RECEPTOR WITH STEROID BINDING POINTS.
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5585490A
(en)
|
1991-10-08 |
1996-12-17 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
|
|
US5212310A
(en)
|
1991-12-19 |
1993-05-18 |
Neurogen Corporation |
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
|
|
WO1993014089A1
(en)
|
1992-01-13 |
1993-07-22 |
Novo Nordisk A/S |
Heterocyclic compounds and their preparation and use
|
|
US5243049A
(en)
|
1992-01-22 |
1993-09-07 |
Neurogen Corporation |
Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
|
|
MX9300875A
(es)
|
1992-02-20 |
1993-08-31 |
Smithkline Beecham Plc |
Procedimiento para la preparacion de compuestos azabiciclicos.
|
|
US6225115B1
(en)
|
1992-03-04 |
2001-05-01 |
Synaptic Pharmaceutical Corporation |
DNA encoding taurine and GABA transporters and uses thereof
|
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
|
US5367077A
(en)
|
1992-04-08 |
1994-11-22 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyridines; a new class of gaba rain receptor ligands
|
|
AU4117493A
(en)
|
1992-04-08 |
1994-11-21 |
Neurogen Corporation |
Certain aryl fused pyrrolopyrimidines; a new class of gaba brain receptor ligands
|
|
US5266698A
(en)
|
1992-04-30 |
1993-11-30 |
Neurogen Corporation |
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
|
|
SE9201478D0
(sv)
*
|
1992-05-11 |
1992-05-11 |
Kabi Pharmacia Ab |
Heteroaromatic quinuclidinenes, their use and preparation
|
|
GB9212673D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
|
GB9212693D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
|
JP2683783B2
(ja)
|
1992-07-10 |
1997-12-03 |
雪印乳業株式会社 |
シェーグレン症候群治療剤
|
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
４−アミノキナゾリン誘導体およびそれを含有する医薬品
|
|
US5306819A
(en)
|
1992-08-27 |
1994-04-26 |
Neurogen Corporation |
Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
|
|
ZA937382B
(en)
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
|
US5668283A
(en)
|
1992-11-12 |
1997-09-16 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
US5286860A
(en)
|
1992-11-12 |
1994-02-15 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
US5622977A
(en)
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
|
GB9226830D0
(en)
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
|
WO1994015937A1
(en)
|
1993-01-06 |
1994-07-21 |
Neurogen Corporation |
Certain aryl substituted imidazopyrazinones a new class of gaba brain receptor ligands
|
|
US5424301A
(en)
|
1993-02-01 |
1995-06-13 |
Warner-Lambert Company |
Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
|
|
US5362860A
(en)
|
1993-02-01 |
1994-11-08 |
Warner-Lambert Company |
Neutral stabilization complex for CI-979 HCl, a cognition activator
|
|
US5527555A
(en)
|
1993-02-16 |
1996-06-18 |
Wisconsin Alumni Research Foundation |
Brazzein sweetener
|
|
JPH06298732A
(ja)
|
1993-02-16 |
1994-10-25 |
Taisho Pharmaceut Co Ltd |
インドール誘導体
|
|
US6013799A
(en)
|
1993-03-03 |
2000-01-11 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimides, a new class of gaba brain receptor ligands
|
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
CA2158952C
(en)
|
1993-03-26 |
1999-05-18 |
Shen-Chun Kuo |
2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
|
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
|
EP0693070B1
(en)
|
1993-04-05 |
2002-07-24 |
Pharmaceutical Discovery Corporation |
PYRIDO[2,3-b](1,4)BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
|
|
JPH06305967A
(ja)
|
1993-04-27 |
1994-11-01 |
Taisho Pharmaceut Co Ltd |
コリン作動性神経不全の改善・治療薬
|
|
DE69435286D1
(de)
|
1993-05-24 |
2010-05-20 |
Purdue Pharma Ltd |
Verfahren und zusammensetzungen zum hervorrufen von schlaf
|
|
US5750702A
(en)
|
1993-10-27 |
1998-05-12 |
Neurogen Corporation |
Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
|
|
GB9311920D0
(en)
|
1993-06-09 |
1993-07-28 |
Pfizer Ltd |
Therapeutic agents
|
|
DE59410119D1
(de)
|
1993-07-02 |
2002-06-20 |
Byk Gulden Lomberg Chem Fab |
Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
|
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
|
JP2983141B2
(ja)
|
1993-10-06 |
1999-11-29 |
株式会社三和化学研究所 |
新規化合物及び該化合物を有効成分とする脳機能改善剤
|
|
US5484944A
(en)
|
1993-10-27 |
1996-01-16 |
Neurogen Corporation |
Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
|
|
JP2818820B2
(ja)
|
1993-11-26 |
1998-10-30 |
ファイザー・インク． |
抗炎症剤としての３−アリール−２−イソオキサゾリン類
|
|
CN1046274C
(zh)
|
1993-11-26 |
1999-11-10 |
辉瑞大药厂 |
用作消炎剂的异噁唑啉化合物
|
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
|
US5500420A
(en)
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
|
EP0738268B1
(en)
|
1993-12-22 |
2004-03-03 |
Celltech R&D Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
|
GB9326600D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
|
GB9326173D0
(en)
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
|
US5668174A
(en)
|
1993-12-29 |
1997-09-16 |
Kowa Tekuno Sachi Co., Ltd. |
Method of treating hyperparathyroidism
|
|
US7060450B1
(en)
|
1993-12-30 |
2006-06-13 |
President And Fellows Of Harvard College |
Screening assays for agonists and antagonists of the hedgehog signaling pathway
|
|
GB9514465D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Chemical compounds
|
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
|
US5939545A
(en)
|
1994-02-14 |
1999-08-17 |
Cocensys, Inc. |
Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
|
|
ES2296594T3
(es)
|
1994-02-14 |
2008-05-01 |
Euro-Celtique S.A. |
Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
|
|
US5696148A
(en)
|
1994-03-14 |
1997-12-09 |
Novo Nordisk A/S |
Indole compounds and their use in treating diseases of the central nervous system
|
|
KR970701719A
(ko)
|
1994-03-14 |
1997-04-12 |
안네 제케르 |
헤테로고리화합물과 그것의 제법 및 사용(heterocyclic compounds, their preparation and use)
|
|
US5783575A
(en)
|
1994-03-14 |
1998-07-21 |
Novo Nordisk A/S |
Antagonists, their preparation and use
|
|
US5637617A
(en)
|
1994-04-01 |
1997-06-10 |
The Regents Of The University Of California |
Methods for use of GABAa receptor GABAergic compounds
|
|
GB9409705D0
(en)
|
1994-05-14 |
1994-07-06 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9409718D0
(en)
|
1994-05-14 |
1994-07-06 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
GB9412672D0
(en)
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
|
JP2852608B2
(ja)
*
|
1994-06-27 |
1999-02-03 |
雪印乳業株式会社 |
口腔乾燥症治療剤
|
|
HUT76923A
(hu)
|
1994-07-27 |
1998-01-28 |
Sankyo Company Limited |
Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
|
|
US5750566A
(en)
|
1994-08-12 |
1998-05-12 |
Eli Lilly And Company |
Synthetic excitatory amino acids
|
|
ATE192157T1
(de)
|
1994-08-24 |
2000-05-15 |
Astra Ab |
Therapeutisch verwendbare spiro-azabicyclische verbindungen
|
|
WO1996006843A1
(en)
|
1994-08-29 |
1996-03-07 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel naphthyridine derivative and medicinal composition thereof
|
|
US5554645A
(en)
|
1994-10-03 |
1996-09-10 |
Mars, Incorporated |
Antineoplastic cocoa extracts and methods for making and using the same
|
|
DE4436509A1
(de)
|
1994-10-13 |
1996-04-18 |
Hoechst Schering Agrevo Gmbh |
Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
|
|
JP3993651B2
(ja)
|
1994-10-21 |
2007-10-17 |
アスビオファーマ株式会社 |
シクロプロパクロメンカルボン酸誘導体
|
|
US5605908A
(en)
|
1994-10-24 |
1997-02-25 |
Eli Lilly And Company |
Heterocyclic compounds and their use
|
|
US5672709A
(en)
*
|
1994-10-24 |
1997-09-30 |
Eli Lilly And Company |
Heterocyclic compounds and their preparation and use
|
|
US6103734A
(en)
*
|
1994-11-04 |
2000-08-15 |
Legarda Ibanez; Juan Jose |
Drug combination as a medicament to suppress the dependence of individuals to opiates
|
|
US5473077A
(en)
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
|
US5571819A
(en)
|
1994-11-22 |
1996-11-05 |
Sabb; Annmarie L. |
Imidazopyridines as muscarinic agents
|
|
NZ298567A
(en)
|
1994-11-23 |
2000-01-28 |
Cocensys Inc |
Androstane and pregnane derivatives, pharmaceutical compositions and methods of treatment
|
|
GB9423910D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
GB9423911D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
US5510478A
(en)
*
|
1994-11-30 |
1996-04-23 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
US5512574A
(en)
|
1994-12-21 |
1996-04-30 |
American Home Products Corporation |
Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
|
|
US5468875A
(en)
*
|
1994-12-22 |
1995-11-21 |
American Home Products Corporation |
1-azabicycloheptane derivatives
|
|
TW304167B
(https=)
|
1995-01-30 |
1997-05-01 |
Lilly Co Eli |
|
|
US5605701A
(en)
|
1995-02-17 |
1997-02-25 |
Eli Lilly And Company |
Transdermal formulation
|
|
PE17897A1
(es)
|
1995-02-17 |
1997-06-12 |
Lilly Co Eli |
Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
|
|
IL117149A0
(en)
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
|
GB9503601D0
(en)
|
1995-02-23 |
1995-04-12 |
Merck Sharp & Dohme |
Method of treatment and method of manufacture of medicament
|
|
AU4844396A
(en)
|
1995-03-01 |
1996-09-18 |
Kyowa Hakko Kogyo Co. Ltd. |
Imidazoquinazoline derivatives
|
|
US5488055A
(en)
|
1995-03-10 |
1996-01-30 |
Sanofi Winthrop Inc. |
Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
|
|
PL183853B1
(pl)
|
1995-04-21 |
2002-07-31 |
Neurosearch As |
Nowa pochodna benzimidazolu i środek farmaceutyczny
|
|
EP0823905A1
(en)
|
1995-05-05 |
1998-02-18 |
Novo Nordisk A/S |
Novel heterocyclic chemistry
|
|
DE19518082A1
(de)
|
1995-05-17 |
1996-11-21 |
Merck Patent Gmbh |
4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one
|
|
ATE231501T1
(de)
|
1995-05-18 |
2003-02-15 |
Altana Pharma Ag |
Phenyldihydrobenzofurane
|
|
DK0828727T3
(da)
|
1995-05-18 |
2003-04-22 |
Altana Pharma Ag |
Cyclohexyldihydrobenzofuraner
|
|
US6514996B2
(en)
|
1995-05-19 |
2003-02-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Derivatives of benzofuran or benzodioxole
|
|
US5637724A
(en)
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
|
US5637725A
(en)
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
|
ATE284895T1
(de)
|
1995-06-06 |
2005-01-15 |
Euro Celtique Sa |
Neuroaktive steroide der androstan- und pregnanreihe
|
|
US5910590A
(en)
|
1995-06-07 |
1999-06-08 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
|
US5534522A
(en)
|
1995-06-07 |
1996-07-09 |
Warner-Lambert Company |
(R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
|
|
AU711104B2
(en)
|
1995-06-22 |
1999-10-07 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9514464D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Medicaments
|
|
CA2227237C
(en)
|
1995-07-26 |
2005-12-13 |
Pfizer Inc. |
N-(aroyl)glycine hydroxamic acid derivatives and related compounds
|
|
US20010018074A1
(en)
|
1995-07-29 |
2001-08-30 |
Smithkline Beecham P.L.C. |
Process for preparing solid dosage forms of very low-dose drugs
|
|
JPH11509846A
(ja)
|
1995-07-31 |
1999-08-31 |
ノボ ノルディスク アクティーゼルスカブ |
ヘテロ環式化合物、それらの調製及び使用
|
|
DE19533975A1
(de)
|
1995-09-14 |
1997-03-20 |
Merck Patent Gmbh |
Arylalkyl-diazinone
|
|
US6166041A
(en)
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
|
HUP9901051A2
(hu)
|
1995-11-06 |
2000-03-28 |
H. Lundbeck A/S |
5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására
|
|
ZA969485B
(en)
|
1995-11-16 |
1998-05-12 |
Lilly Co Eli |
Excitatory amino acid receptor antagonists.
|
|
US5912248A
(en)
|
1995-11-16 |
1999-06-15 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
|
US5688826A
(en)
|
1995-11-16 |
1997-11-18 |
Eli Lilly And Company |
Excitatory amino acid derivatives
|
|
IT1276153B1
(it)
|
1995-11-17 |
1997-10-27 |
Roberto Pellicciari |
Derivati di glicina ad attivita' antagonista dei recettori metabotropi del glutammato
|
|
US6051681A
(en)
*
|
1995-11-17 |
2000-04-18 |
Dsm N.V. |
Process for the preparation of a thermoplastic elastomer
|
|
GB9523675D0
(en)
*
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5756501A
(en)
|
1995-12-13 |
1998-05-26 |
American Home Products Corporation |
Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
|
|
US5710170A
(en)
|
1995-12-15 |
1998-01-20 |
Merck Frosst Canada, Inc. |
Tri-aryl ethane derivatives as PDE IV inhibitors
|
|
GB9603723D0
(en)
|
1996-02-22 |
1996-04-24 |
Merck & Co Inc |
Diphenyl pyridyl derivatives as pde iv inhibitors
|
|
GB9526243D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9526246D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9526245D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5804686A
(en)
|
1996-01-19 |
1998-09-08 |
Neurogen Corporation |
fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
|
US6211365B1
(en)
|
1996-01-19 |
2001-04-03 |
Neurogen Corporation |
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
|
BR9707233A
(pt)
|
1996-01-31 |
1999-07-20 |
Byk Gulden Lomberg Chem Fab |
Fenantridinas
|
|
GB9604926D0
(en)
|
1996-03-08 |
1996-05-08 |
Sandoz Ltd |
Organic compounds
|
|
US5792766A
(en)
|
1996-03-13 |
1998-08-11 |
Neurogen Corporation |
Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
|
|
WO1997034870A1
(en)
|
1996-03-22 |
1997-09-25 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides as gaba brain receptor ligands
|
|
US5677309A
(en)
|
1996-03-22 |
1997-10-14 |
Neurogen Corporation |
1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands
|
|
US6127378A
(en)
|
1996-03-26 |
2000-10-03 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenanthridines substituted in the 6 position
|
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
FR2746800B1
(fr)
|
1996-03-29 |
1998-06-05 |
Jouveinal Inst Rech |
Diazepino-indoles inhibiteurs de phosphodiesterases 4
|
|
US6297273B1
(en)
|
1996-04-02 |
2001-10-02 |
Mars, Inc. |
Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
|
|
FR2754260B1
(fr)
|
1996-10-04 |
1998-10-30 |
Adir |
Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
ES2180998T3
(es)
|
1996-04-23 |
2003-02-16 |
Lilly Co Eli |
Compuestos heterociclicos.
|
|
US5723462A
(en)
|
1996-04-26 |
1998-03-03 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
|
|
EP0805153B1
(en)
|
1996-04-30 |
2001-11-14 |
Pfizer Inc. |
Novel muscarinic receptor agonists
|
|
US20020103194A1
(en)
*
|
1997-04-30 |
2002-08-01 |
Anabella Villalobos |
Novel muscarinic receptor agonists
|
|
AP1147A
(en)
|
1996-05-03 |
2003-02-25 |
Pfizer |
Substituted indazole derivatives and related compounds.
|
|
BR9709230A
(pt)
|
1996-05-10 |
1999-08-10 |
Icos Corp |
Composto
|
|
ATE239004T1
(de)
|
1996-05-20 |
2003-05-15 |
Darwin Discovery Ltd |
Benzofuran carboxamide und ihre therapeutische anwendung
|
|
CZ296163B6
(cs)
|
1996-05-20 |
2006-01-11 |
|
Karboxyamidy chinolinu jako inhibitory TNF a inhibitory PDE-IV
|
|
AU722662B2
(en)
|
1996-05-20 |
2000-08-10 |
Darwin Discovery Limited |
Quinoline sulfonamides as TNF inhibitors and as PDE-IV inhibitors
|
|
JP4373497B2
(ja)
|
1996-06-19 |
2009-11-25 |
ローン−プーラン・ロレ・リミテツド |
置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
|
|
SI0912558T1
(en)
|
1996-06-25 |
2003-10-31 |
Pfizer Inc. |
Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
|
|
US6017924A
(en)
|
1996-06-27 |
2000-01-25 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
EP0913389A4
(en)
|
1996-06-28 |
2000-02-02 |
Nippon Chemiphar Co |
CYCLOPROPYLGLYCINE DERIVATIVES AND AGONISTS OF THE L-GLUTAMATE RECEPTOR TYPE OF METABOLITE REGULATION
|
|
ATE224884T1
(de)
|
1996-07-01 |
2002-10-15 |
Schering Corp |
Muscarin-antagonisten
|
|
GB9614718D0
(en)
|
1996-07-12 |
1996-09-04 |
Bayer Ag |
3-ureido-pyridofurans and -pyridothiophenes
|
|
DE19628621A1
(de)
|
1996-07-16 |
1998-01-22 |
Byk Gulden Lomberg Chem Fab |
Neue 4-substituierte Benzofurane
|
|
KR20000029548A
(ko)
|
1996-07-25 |
2000-05-25 |
더블유. 지. 콜 |
가바수용체에대한리간드로서의치환된트리아졸로-피리다진유도체
|
|
US20020127271A1
(en)
|
1996-07-25 |
2002-09-12 |
Smithkline Beecham P.L.C. |
Formulation for the treatment and/or prophylaxis of dementia
|
|
WO1998004560A1
(en)
|
1996-07-25 |
1998-02-05 |
Merck Sharp & Dohme Limited |
SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE
|
|
WO1998005337A1
(en)
|
1996-08-01 |
1998-02-12 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
|
BR9711154A
(pt)
|
1996-08-12 |
1999-08-17 |
Yoshitomi Pharmaceutical |
Agente farmac-utico contendo inibidor cinase rho
|
|
DE19632549A1
(de)
|
1996-08-13 |
1998-02-19 |
Merck Patent Gmbh |
Arylalkanoylpyridazine
|
|
JP4309475B2
(ja)
|
1996-08-19 |
2009-08-05 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規のベンゾフラン―４―カルボキサミド
|
|
PT920426E
(pt)
|
1996-08-26 |
2004-02-27 |
Altana Pharma Ag |
Novos derivados de tiazole com efeito inibidor de fosfodiesterase
|
|
US6312753B1
(en)
|
1996-09-06 |
2001-11-06 |
Mars, Incorporated |
Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
|
|
US6015913A
(en)
|
1996-09-06 |
2000-01-18 |
Mars, Incorporated |
Method for producing fat and/or solids from cocoa beans
|
|
US20010003588A1
(en)
|
1996-09-12 |
2001-06-14 |
Smithkline Beecham Corporation |
Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
|
|
SK285878B6
(sk)
|
1996-10-02 |
2007-10-04 |
Janssen Pharmaceutica N. V. |
Derivát 2-kyaniminoimidazolu, prostriedok obsahujúci tento derivát, spôsob prípravy tohto prostriedku, uvedený derivát na použitie ako liečivo, použitie tohto derivátu na prípravu liečiva a spôsob prípravy tohto derivátu
|
|
US5834458A
(en)
*
|
1996-10-09 |
1998-11-10 |
Eli Lilly And Company |
Heterocyclic compounds and their use
|
|
WO1998016528A1
(en)
|
1996-10-11 |
1998-04-23 |
Chiron Corporation |
Purine inhibitors of glycogen synthase kinase 3 (gsk3)
|
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
|
GB9621789D0
(en)
|
1996-10-18 |
1996-12-11 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
WO1998017651A1
(en)
|
1996-10-21 |
1998-04-30 |
Neurosearch A/S |
1-phenyl-benzimidazole compounds and their use as baga-a receptor modulators
|
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
US5773458A
(en)
|
1996-10-30 |
1998-06-30 |
American Home Products Corporation |
1-azabicycloheptane derivatives
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
DE69723863T2
(de)
|
1996-11-06 |
2004-04-15 |
Darwin Discovery Ltd., Slough |
Chinoline und deren therapeutische verwendung
|
|
US6069151A
(en)
|
1996-11-06 |
2000-05-30 |
Darwin Discovery, Ltd. |
Quinolines and their therapeutic use
|
|
WO1998021207A1
(de)
|
1996-11-12 |
1998-05-22 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
(2,3-dihydrobenzofuranyl)-thiazole als phosphodiesterasehemmer
|
|
US6054475A
(en)
|
1996-11-20 |
2000-04-25 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders
|
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
BR9806752A
(pt)
|
1997-01-15 |
2000-03-14 |
Byk Gulden Lomberg Chem Fab |
Ftalazinonas.
|
|
GB9702524D0
(en)
|
1997-02-07 |
1997-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2302350T3
(es)
|
1997-02-28 |
2008-07-01 |
Nycomed Gmbh |
Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa.
|
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
|
JP2001520653A
(ja)
*
|
1997-04-11 |
2001-10-30 |
エリ リリー アンド カンパニー |
精神分裂病の治療法
|
|
PT975327E
(pt)
|
1997-04-18 |
2003-11-28 |
Janssen Pharmaceutica Nv |
Uso de antagonistas de 5ht3 para estimular a lavagem intestinal
|
|
DE69830840D1
(de)
*
|
1997-04-22 |
2005-08-18 |
Novo Nordisk As |
Heterozyklische verbindungen, ihre herstellung und ihre anwendung
|
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6387673B1
(en)
|
1997-05-01 |
2002-05-14 |
The Salk Institute For Biological Studies |
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
|
|
US6043252A
(en)
|
1997-05-05 |
2000-03-28 |
Icos Corporation |
Carboline derivatives
|
|
CA2288789C
(en)
|
1997-05-08 |
2009-07-21 |
Merck Sharp & Dohme Limited |
Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
|
|
ZA983930B
(en)
|
1997-05-14 |
1999-11-08 |
Lilly Co Eli |
Excitatory amino acid receptor modulators.
|
|
EP1014974B1
(en)
|
1997-05-29 |
2004-08-11 |
H. Lundbeck A/S |
Treatment of schizophrenia and psychosis
|
|
GB9713707D0
(en)
|
1997-06-27 |
1997-09-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6825211B1
(en)
|
1997-07-18 |
2004-11-30 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
|
JP2001515839A
(ja)
|
1997-07-18 |
2001-09-25 |
ジョージタウン・ユニバーシティ |
二環式向代謝性グルタミン酸受容体リガンド
|
|
JP2001510797A
(ja)
|
1997-07-22 |
2001-08-07 |
イーライ・リリー・アンド・カンパニー |
医薬化合物
|
|
JP2001510827A
(ja)
|
1997-07-25 |
2001-08-07 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
置換６−フェニルフェナントリジン
|
|
GB9715977D0
(en)
|
1997-07-29 |
1997-10-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2137113B1
(es)
|
1997-07-29 |
2000-09-16 |
Almirall Prodesfarma Sa |
Nuevos derivados de triazolo-piridazinas heterociclicos.
|
|
US6107295A
(en)
|
1997-08-01 |
2000-08-22 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Arylalkanoyl pyridazines
|
|
CA2268190A1
(en)
|
1997-08-06 |
1999-02-18 |
Suntory Limited |
1-aryl-1,8-naphthylidin-4-one derivative as type iv phosphodiesterase inhibitor
|
|
US6143760A
(en)
|
1997-08-25 |
2000-11-07 |
Neurogen Corporation |
Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
|
|
JP2001518503A
(ja)
|
1997-10-02 |
2001-10-16 |
ハー・ルンドベック・アクチエゼルスカベット |
５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジンの粒状調合物
|
|
US6207842B1
(en)
|
1997-10-09 |
2001-03-27 |
Mars Incorporated |
Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
|
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
|
US6127363A
(en)
|
1997-10-28 |
2000-10-03 |
Vivus, Inc. |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
US6156753A
(en)
|
1997-10-28 |
2000-12-05 |
Vivus, Inc. |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
CA2395558C
(en)
|
1997-11-12 |
2007-07-17 |
Bayer Aktiengesellschaft |
Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
|
|
WO1999025353A1
(en)
|
1997-11-13 |
1999-05-27 |
Merck Sharp & Dohme Limited |
Therapeutic uses of triazolo-pyridazine derivatives
|
|
GB9723999D0
(en)
*
|
1997-11-13 |
1998-01-14 |
Merck Sharp & Dohme |
Therapeutic use
|
|
US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
|
CN1294590A
(zh)
|
1997-12-12 |
2001-05-09 |
欧罗赛铁克股份有限公司 |
通过2－硫代黄嘌呤制备3－取代腺嘌呤的方法
|
|
IT1296985B1
(it)
|
1997-12-19 |
1999-08-03 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
|
CA2315219A1
(en)
|
1998-01-14 |
1999-07-22 |
Merck Sharp & Dohme Limited |
Triazolo-pyridazine derivatives as ligands for gaba receptors
|
|
GB9801210D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801234D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
HUP0100575A3
(en)
|
1998-01-21 |
2003-03-28 |
Merck Sharp & Dohme Ltd Hoddes |
Triazolo-pyridazine derivatives as ligands for gaba receptors
|
|
GB9801202D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801208D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9801397D0
(en)
|
1998-01-22 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
HUP0002353A3
(en)
|
1998-01-29 |
2001-11-28 |
Daiichi Asubio Pharma Co Ltd |
1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phoshodiesterase iv inhibitory activity and pharmaceutical compositions containing them
|
|
US6166203A
(en)
|
1998-02-26 |
2000-12-26 |
Neurogen Corporation |
Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands
|
|
AU2881199A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
|
|
US6103903A
(en)
|
1998-02-26 |
2000-08-15 |
Neurogen Corporation |
4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands
|
|
EP1056724B1
(en)
|
1998-02-26 |
2005-05-25 |
Neurogen Corporation |
Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
|
|
US6900228B1
(en)
|
1998-03-10 |
2005-05-31 |
Research Triangle Institute |
Opiate compounds, methods of making and methods of use
|
|
US6805883B2
(en)
|
1998-03-12 |
2004-10-19 |
Mars, Incorporated |
Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
|
|
ATE251624T1
(de)
|
1998-03-13 |
2003-10-15 |
Univ British Columbia |
Granulatimide-derivate zur behandlung von krebs
|
|
GB9806102D0
(en)
|
1998-03-20 |
1998-05-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
FR2776660B1
(fr)
|
1998-03-27 |
2000-05-12 |
Parke Davis |
Diazepino-indoles de phosphodiesterases iv
|
|
BR9909277A
(pt)
|
1998-03-31 |
2001-10-16 |
Acadia Pharm Inc |
Compostos com atividade em receptores muscarìnicos
|
|
US6528529B1
(en)
*
|
1998-03-31 |
2003-03-04 |
Acadia Pharmaceuticals Inc. |
Compounds with activity on muscarinic receptors
|
|
WO1999054280A1
(en)
|
1998-04-17 |
1999-10-28 |
Kenneth Curry |
Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
|
|
RS50011B
(sr)
|
1998-04-20 |
2008-09-29 |
Pfizer Inc., |
Derivati piridin-3-karboksilne kiseline i njihova upotreba kao intermedijera
|
|
PL198983B1
(pl)
|
1998-04-28 |
2008-08-29 |
Elbion Ag |
Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 oraz sposoby ich wytwarzania
|
|
HUP0101901A3
(en)
*
|
1998-05-22 |
2002-06-28 |
Lilly Co Eli |
Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
|
|
US6897305B2
(en)
|
1998-06-08 |
2005-05-24 |
Theravance, Inc. |
Calcium channel drugs and uses
|
|
PT1086096E
(pt)
|
1998-06-10 |
2003-12-31 |
Altana Pharma Ag |
Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
|
|
DE19826841A1
(de)
|
1998-06-16 |
1999-12-23 |
Merck Patent Gmbh |
Arylalkanoylpyridazine
|
|
GB9813006D0
(en)
|
1998-06-16 |
1998-08-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1087968A1
(en)
|
1998-06-16 |
2001-04-04 |
MERCK SHARP & DOHME LTD. |
Triazolo-pyridine derivatives as ligands for gaba receptors
|
|
WO1999065897A1
(en)
|
1998-06-19 |
1999-12-23 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
JP2002519423A
(ja)
|
1998-07-06 |
2002-07-02 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
Ｐｅｄ阻害作用を有する新規ベンゾオキサゾール
|
|
ITMI981671A1
(it)
|
1998-07-21 |
2000-01-21 |
Zambon Spa |
Derivati ftalazinici inibitori della fosfodisterasi 4
|
|
US6177569B1
(en)
|
1998-08-25 |
2001-01-23 |
Neurogen Corporation |
Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
|
|
EP1107738A4
(en)
|
1998-08-27 |
2003-01-22 |
Bristol Myers Squibb Co |
Novel pharmaceutical salt form
|
|
KR100469182B1
(ko)
|
1998-08-31 |
2005-02-02 |
다이쇼 세이야꾸 가부시끼가이샤 |
6-플루오로비시클로[3.1.0]헥산 유도체
|
|
MXPA01002102A
(es)
|
1998-09-03 |
2003-02-24 |
Kyowa Hakko Kogyo Kk |
Compuestos heterociclicos que contienen oxigeno.
|
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
|
AU1025899A
(en)
|
1998-09-16 |
2000-04-03 |
Icos Corporation |
Carboline derivatives as cgmp phosphodiesterase inhibitors
|
|
EP1115718A1
(en)
|
1998-09-24 |
2001-07-18 |
Mitsubishi Chemical Corporation |
Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
|
|
AR023052A1
(es)
|
1998-09-25 |
2002-09-04 |
Mitsuharu Yoshimura Milton |
Derivados de pirimidona
|
|
US6719520B2
(en)
|
1998-10-08 |
2004-04-13 |
Smithkline Beecham Corporation |
Method and compounds
|
|
AU6111699A
(en)
|
1998-10-08 |
2000-05-01 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
ATE371659T1
(de)
|
1998-10-16 |
2007-09-15 |
Merck Sharp & Dohme |
Pyrazolotriazinderivate als gaba-rezeptorliganden
|
|
DE19850701A1
(de)
|
1998-11-04 |
2000-05-11 |
Merck Patent Gmbh |
Benzoylpyridazine
|
|
WO2000027849A2
(en)
|
1998-11-12 |
2000-05-18 |
Merck & Co., Inc. |
Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
|
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
|
SE9804064D0
(sv)
|
1998-11-25 |
1998-11-25 |
A & Science Invest Ab |
Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
|
|
US6130333A
(en)
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
|
GB9828640D0
(en)
|
1998-12-23 |
1999-02-17 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
WO2000037471A1
(en)
|
1998-12-23 |
2000-06-29 |
Neurogen Corporation |
2-amino-9-alkylpurines: gaba brain receptor ligands
|
|
ATE284403T1
(de)
|
1999-01-27 |
2004-12-15 |
Merck Sharp & Dohme |
Triazolopyridazinderivate als liganden für gaba- rezeptoren
|
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
|
US6498176B1
(en)
|
1999-03-04 |
2002-12-24 |
Smithklinebeecham Corporation |
3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
|
|
TW575561B
(en)
|
1999-03-25 |
2004-02-11 |
Hoffmann La Roche |
1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
|
|
DE19915365A1
(de)
|
1999-04-06 |
2000-10-12 |
Merck Patent Gmbh |
Tetrahydropyridazin-Derivate
|
|
AU773915B2
(en)
|
1999-04-28 |
2004-06-10 |
Georgetown University |
Ligands for metabotropic glutamate receptors
|
|
FR2792938B1
(fr)
|
1999-04-28 |
2001-07-06 |
Warner Lambert Co |
NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
US6943166B1
(en)
|
1999-04-30 |
2005-09-13 |
Lilly Icos Llc. |
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
|
|
US6316472B1
(en)
|
1999-05-13 |
2001-11-13 |
Merck Frosst Canada & Co. |
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
|
|
WO2000071528A1
(en)
|
1999-05-25 |
2000-11-30 |
Neurogen Corporation |
4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
|
|
EP1189873A1
(en)
|
1999-06-03 |
2002-03-27 |
Lilly, S.A. |
Excitatory amino acid receptor modulators
|
|
WO2000077045A1
(fr)
|
1999-06-10 |
2000-12-21 |
Takeda Chemical Industries, Ltd. |
Proteine et adn de cette proteine
|
|
US6146876A
(en)
|
1999-06-11 |
2000-11-14 |
Millennium Pharmaceuticals, Inc. |
22025, a novel human cyclic nucleotide phosphodiesterase
|
|
US6297256B1
(en)
|
1999-06-15 |
2001-10-02 |
Neurogen Corporation |
Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
|
|
DE19928146A1
(de)
|
1999-06-19 |
2000-12-21 |
Merck Patent Gmbh |
Thienopyrimidine
|
|
IL147309A0
(en)
|
1999-07-21 |
2002-08-14 |
Fujisawa Pharmaceutical Co |
Benzimidazolone derivatives and pharmaceutical compositions containg the same
|
|
GB9918180D0
(en)
|
1999-08-02 |
1999-10-06 |
Smithkline Beecham Plc |
Novel compositions
|
|
US6821975B1
(en)
|
1999-08-03 |
2004-11-23 |
Lilly Icos Llc |
Beta-carboline drug products
|
|
US20050137206A1
(en)
|
1999-08-05 |
2005-06-23 |
Yevich Joseph P. |
Method for treatment of anxiety and depression
|
|
ES2209728T3
(es)
|
1999-08-06 |
2004-07-01 |
F. Hoffmann-La Roche Ag |
Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
ATE443526T1
(de)
*
|
1999-08-20 |
2009-10-15 |
Takeda Pharmaceutical |
Zusammensetzung für perkutane absorption mit einem melantoninrezeptor-agonistisch wirkendem wirkstoff
|
|
US6313159B1
(en)
|
1999-08-20 |
2001-11-06 |
Guilford Pharmaceuticals Inc. |
Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
|
|
GB9919957D0
(en)
|
1999-08-23 |
1999-10-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
KR20020038741A
(ko)
|
1999-08-27 |
2002-05-23 |
윌리암 엘. 레스페스 |
안드로겐 수용체 조절 화합물 및 방법
|
|
JP2003508397A
(ja)
|
1999-08-27 |
2003-03-04 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物
|
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
US6956049B1
(en)
|
1999-08-31 |
2005-10-18 |
Merck & Co., Inc. |
Methods of modulating processes mediated by excitatory amino acid receptors
|
|
US20050014939A1
(en)
|
1999-08-31 |
2005-01-20 |
Neurogen Corporation |
Fused pyrrolecarboxamides: GABA brain receptor ligands
|
|
GB9921150D0
(en)
|
1999-09-07 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9921351D0
(en)
|
1999-09-09 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CN1374953A
(zh)
|
1999-09-16 |
2002-10-16 |
田边制药株式会社 |
含氮的6－员芳香环化合物
|
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
ATE261945T1
(de)
|
1999-10-15 |
2004-04-15 |
Hoffmann La Roche |
Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
|
|
US7491742B2
(en)
|
1999-10-21 |
2009-02-17 |
Merck Patent Gmbh |
Imidazole derivatives as phosphodiesterase VII inhibitors
|
|
TWI262919B
(en)
|
1999-10-25 |
2006-10-01 |
Yamanouchi Pharma Co Ltd |
Naphthyridine derivative
|
|
US6534287B1
(en)
|
1999-10-25 |
2003-03-18 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
|
DE19953025A1
(de)
|
1999-11-04 |
2001-05-10 |
Merck Patent Gmbh |
Pyrrolderivate als Phosphodiesterase VII-Hemmer
|
|
US6333357B1
(en)
*
|
1999-11-05 |
2001-12-25 |
Be Able, Llc |
Behavior chemotherapy
|
|
DE19953414A1
(de)
|
1999-11-06 |
2001-05-10 |
Merck Patent Gmbh |
Imidazopyridinderivate als Phospodiesterase VII-Hemmer
|
|
DE19954707A1
(de)
|
1999-11-13 |
2001-05-17 |
Merck Patent Gmbh |
Imidazolverbindungen als Phosphodiesterase VII-Hemmer
|
|
EP1748046A3
(en)
|
1999-11-23 |
2007-08-22 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
GB9927687D0
(en)
|
1999-11-23 |
2000-01-19 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
FR2801216A1
(fr)
|
1999-11-23 |
2001-05-25 |
Centre Nat Rech Scient |
Utilisation de derives d'indirubine pour la fabrication de medicaments
|
|
CN1224624C
(zh)
|
1999-12-08 |
2005-10-26 |
格勒兰制药株式会社 |
1,8－二氮杂萘－2(1h)－酮衍生物
|
|
ES2213996T3
(es)
|
1999-12-08 |
2004-09-01 |
Centre National De La Recherche Scientifique (Cnrs) |
Uso de himenialdisina o sus derivados en la fabricacion de medicamentos.
|
|
WO2001042224A1
(en)
|
1999-12-09 |
2001-06-14 |
Mitsubishi Pharma Corporation |
Carboxyamido derivatives
|
|
GB9929687D0
(en)
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6680336B2
(en)
|
1999-12-15 |
2004-01-20 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
GB9929685D0
(en)
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6376489B1
(en)
|
1999-12-23 |
2002-04-23 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
CN100335479C
(zh)
|
1999-12-17 |
2007-09-05 |
希龙公司 |
糖元合成酶激酶3的双环抑制剂
|
|
JP2003516974A
(ja)
|
1999-12-17 |
2003-05-20 |
カイロン コーポレイション |
グリコーゲンシンターゼキナーゼ３のピラジンベースインヒビター
|
|
US6362213B1
(en)
|
1999-12-23 |
2002-03-26 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6313156B1
(en)
|
1999-12-23 |
2001-11-06 |
Icos Corporation |
Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
|
|
US6258833B1
(en)
|
1999-12-23 |
2001-07-10 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6569885B1
(en)
|
1999-12-23 |
2003-05-27 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6348602B1
(en)
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6294561B1
(en)
|
1999-12-23 |
2001-09-25 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
|
GB0000564D0
(en)
|
2000-01-11 |
2000-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CZ20022413A3
(cs)
|
2000-01-31 |
2003-08-13 |
Pfizer Products Inc. |
Pyrimidinkarboxamidy užitečné jako inhibitory isozymů PDE4
|
|
JP2003523741A
(ja)
|
2000-02-01 |
2003-08-12 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
Ｂｃｌ−２様ポリヌクレオチド、ポリペプチドおよび抗体
|
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
AU2001230026A1
(en)
|
2000-02-04 |
2001-08-14 |
Novo-Nordisk A/S |
2,4-diaminothiazole derivatives
|
|
US20010039275A1
(en)
|
2000-02-04 |
2001-11-08 |
Bowler Andrew Neil |
Use of 2,4-diaminothiazole derivatives
|
|
GB0003254D0
(en)
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
FR2804959B1
(fr)
|
2000-02-15 |
2006-04-28 |
Centre Nat Rech Scient |
Utilisation de derives de paullones pour la fabrication de medicaments
|
|
GB0005700D0
(en)
|
2000-03-09 |
2000-05-03 |
Glaxo Group Ltd |
Therapy
|
|
EP1136485A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
Aminophenyl pyrimidone derivatives
|
|
EP1136482A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
|
|
EP1136486A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-[Indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives
|
|
JP2005289808A
(ja)
|
2000-03-23 |
2005-10-20 |
Sanofi-Aventis |
３−置換−４−ピリミドン誘導体
|
|
AU2001262150A1
(en)
|
2000-03-23 |
2001-10-03 |
Mitsubishi Pharma Corporation |
2-(nitrogen-heterocyclic)pyrimidone derivatives
|
|
DE60125026T2
(de)
|
2000-03-23 |
2007-06-28 |
Takeda Pharmaceutical Co. Ltd. |
Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
|
|
WO2001070727A1
(en)
|
2000-03-23 |
2001-09-27 |
Sanofi-Synthelabo |
2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
|
|
WO2001070675A2
(en)
|
2000-03-24 |
2001-09-27 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
|
US6683192B2
(en)
|
2000-03-30 |
2004-01-27 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
GB0008264D0
(en)
|
2000-04-04 |
2000-05-24 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
GB0008696D0
(en)
|
2000-04-07 |
2000-05-31 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0008921D0
(en)
*
|
2000-04-11 |
2000-05-31 |
Smithkline Beecham Plc |
Method of treatment
|
|
EP1274319B1
(en)
|
2000-04-14 |
2009-08-12 |
Mars, Incorporated |
Compositions and methods for improving vascular health
|
|
CA2306170A1
(en)
|
2000-04-18 |
2001-10-18 |
Kenneth Curry |
Novel amino, carboxy derivatives of barbituric acid
|
|
WO2001081345A1
(en)
|
2000-04-20 |
2001-11-01 |
Mitsubishi Pharma Corporation |
Aromatic amide compounds
|
|
AR028385A1
(es)
*
|
2000-04-28 |
2003-05-07 |
Acadia Pharm Inc |
Agonistas muscarinicos
|
|
US20010036949A1
(en)
*
|
2000-05-09 |
2001-11-01 |
Coe Jotham Wadsworth |
Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
|
|
NZ522674A
(en)
|
2000-05-11 |
2004-10-29 |
Kenneth Curry |
Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof
|
|
AU783615B2
(en)
|
2000-05-11 |
2005-11-17 |
Consejo Superior De Investigaciones Cientificas |
Heterocyclic inhibitors of glycogen synthase kinase GSK-3
|
|
UA74826C2
(en)
|
2000-05-17 |
2006-02-15 |
Ortho Mcneil Pharm Inc |
?-carboline derivatives as phosphodiesterase inhibitors
|
|
UA72611C2
(uk)
|
2000-05-17 |
2005-03-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
|
|
EP1294723A1
(en)
|
2000-05-24 |
2003-03-26 |
MERCK SHARP & DOHME LTD. |
3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
|
|
EP1289383B1
(fr)
|
2000-05-30 |
2006-05-03 |
Societe Des Produits Nestle S.A. |
Composition primaire contenant un compose bioactif lipophile
|
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
|
WO2001094350A1
(en)
|
2000-06-07 |
2001-12-13 |
Almirall Prodesfarma S.A. |
6-phenylpyrrolopyrimidinedione derivatives
|
|
MXPA02012470A
(es)
|
2000-06-23 |
2004-01-26 |
Lilly Icos Llc |
Inhibidores de fosfodiesterasa especificos para gmp ciclico.
|
|
JP2004502655A
(ja)
*
|
2000-06-30 |
2004-01-29 |
イーライ・リリー・アンド・カンパニー |
精神病の処置のための組み合わせ療法
|
|
US6589978B2
(en)
|
2000-06-30 |
2003-07-08 |
Hoffman-La Roche Inc. |
1-sulfonyl pyrrolidine derivatives
|
|
US6399641B1
(en)
|
2000-07-13 |
2002-06-04 |
Hoffmann-La Roche Inc. |
2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
|
|
MXPA03000504A
(es)
|
2000-07-19 |
2003-06-24 |
Hoffmann La Roche |
Derivados de pirimidina.
|
|
CA2417277A1
(en)
|
2000-07-27 |
2002-02-07 |
F. Hoffmann-La Roche Ag |
3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta.
|
|
GB0018473D0
(en)
|
2000-07-27 |
2000-09-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
|
EP1307201B1
(de)
|
2000-08-01 |
2004-11-24 |
Bayer HealthCare AG |
Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
US6237645B1
(en)
*
|
2000-08-17 |
2001-05-29 |
David B. Pountney |
Boat fuel overflow protection system
|
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
|
NZ523656A
(en)
|
2000-08-31 |
2004-11-26 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
AR030587A1
(es)
|
2000-09-01 |
2003-08-27 |
Sanofi Aventis |
Derivados de 2-piridinil-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona y 7-piridinil-2,3-dihidroimidazo[1,2-a]pirimidin-5(1h)-ona
|
|
EP1184384A1
(en)
|
2000-09-01 |
2002-03-06 |
Sanofi-Synthelabo |
1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives
|
|
AU9502601A
(en)
|
2000-09-06 |
2002-03-22 |
Chiron Corp |
Inhibitors of glycogen synthase kinase 3
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
BR0114080A
(pt)
|
2000-09-22 |
2003-07-29 |
Mars Uk Ltd |
Suplemento alimentìcio, uso do mesmo, método para auxiliar a prevenção ou tratamento de dano oxidativo, alimento, e, métodos para fabricar o mesmo, e para melhorar ou aumentar a produção de trabalho de um animal
|
|
JP4975941B2
(ja)
|
2000-09-29 |
2012-07-11 |
トポターゲット ユーケー リミテッド |
（ｅ）−ｎ−ヒドロキシ−３−（３−スルファモイル−フェニル）アクリルアミド化合物及びその治療用途
|
|
EP1335898B1
(en)
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
JP3830746B2
(ja)
|
2000-09-29 |
2006-10-11 |
スガツネ工業株式会社 |
ヒンジ装置
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
CZ20031145A3
(cs)
|
2000-10-02 |
2003-12-17 |
Janssen Pharmaceutica N.V. |
Antagonisté metabotropního glutamátového receptoru
|
|
EP1193261A1
(en)
|
2000-10-02 |
2002-04-03 |
Warner-Lambert Company |
New thiadiazoles and their use as phosphodiesterase-7 inhibitors
|
|
WO2002032896A1
(en)
|
2000-10-16 |
2002-04-25 |
Novo Nordisk A/S |
Furazanyl-triazole derivates for the treatment of diseases
|
|
US20020103192A1
(en)
|
2000-10-26 |
2002-08-01 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
GB0117277D0
(en)
|
2001-07-16 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0027561D0
(en)
|
2000-11-10 |
2000-12-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2427779A1
(en)
|
2000-11-10 |
2002-05-16 |
Merck Sharp & Dohme Limited |
Imidazo-triazine derivatives as ligands for gaba receptors
|
|
CZ20031334A3
(cs)
|
2000-11-14 |
2003-09-17 |
Altana Pharma Ag |
Isochinolinové deriváty a jejich použití jako inhibitory
|
|
AR035659A1
(es)
|
2000-12-07 |
2004-06-23 |
Hoffmann La Roche |
Hidroxiamidas de acido (1-oxo-1,2,3,4-tetrahidro-naftalen-2-il)-alcanoico, proceso para la manufactura de estos compuestos, composiciones farmaceuticas que contienen dichos compuestos y los usos de los mismos
|
|
US6930114B2
(en)
|
2000-12-13 |
2005-08-16 |
Bayer Pharmaceuticals Corporation |
Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
|
|
US6900215B2
(en)
|
2000-12-15 |
2005-05-31 |
Merck Sharp & Dohme Ltd. |
Imidazo-pyrimidine derivatives as ligands for gaba receptors
|
|
US6720445B2
(en)
|
2000-12-21 |
2004-04-13 |
Beacon Laboratories, Inc. |
Acetyloxymethyl esters and methods for using the same
|
|
US6562995B1
(en)
|
2000-12-21 |
2003-05-13 |
Beacon Laboratories, Inc. |
Delta dicarbonyl compounds and methods for using the same
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
KR100545906B1
(ko)
|
2000-12-22 |
2006-01-26 |
에프. 호프만-라 로슈 아게 |
ｍＧｌｕＲ 1 길항물질로서의 테트라하이드로-(벤조 또는티에노)-아제핀-피라진 및 트리아진 유도체
|
|
AR035513A1
(es)
|
2000-12-23 |
2004-06-02 |
Hoffmann La Roche |
Derivados de tetrahidropiridina, proceso para prepararlos, composiciones farmaceuticas que los contienen, y uso de dichos compuestos en la preparacion de medicamentos
|
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
US6974824B2
(en)
|
2001-01-08 |
2005-12-13 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
AR035417A1
(es)
|
2001-01-27 |
2004-05-26 |
Hoffmann La Roche |
Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
|
|
EE200300360A
(et)
|
2001-01-31 |
2003-12-15 |
Pfizer Products Inc. |
PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
|
|
CN1489588A
(zh)
|
2001-01-31 |
2004-04-14 |
�Ʒ� |
用作pde4同功酶抑制剂的噻唑基,噁唑基,吡咯基,和咪唑基羧酸酰胺衍生物
|
|
ES2248231T3
(es)
|
2001-01-31 |
2006-03-16 |
Pfizer Products Inc. |
Derivados de eteres utiles como inhibidores de las isozimas pde4.
|
|
US6559159B2
(en)
|
2001-02-01 |
2003-05-06 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
US6617357B2
(en)
|
2001-03-06 |
2003-09-09 |
Smithkline Beecham Corporation |
Compounds and their use as PDE inhibitors
|
|
US20020177594A1
(en)
|
2001-03-14 |
2002-11-28 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
AP1699A
(en)
|
2001-03-21 |
2006-12-26 |
Warner Lambert Co |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
|
CA2442330A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
GB0111191D0
(en)
|
2001-05-08 |
2001-06-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002089782A2
(en)
|
2001-05-09 |
2002-11-14 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
AU2002314102A1
(en)
|
2001-05-25 |
2002-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
|
|
IL158776A0
(en)
|
2001-05-25 |
2004-05-12 |
Pfizer |
A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
|
|
MXPA03010961A
(es)
|
2001-05-31 |
2004-02-27 |
Vertex Pharma |
Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
DE10130167A1
(de)
|
2001-06-22 |
2003-01-02 |
Bayer Ag |
Imidazotriazine
|
|
SE0102440D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compound
|
|
GB0117060D0
(en)
|
2001-07-12 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2003029331A
(ja)
|
2001-07-13 |
2003-01-29 |
Sano Fuji Koki Co Ltd |
反射型液晶プロジェクタ
|
|
EP1417203A4
(en)
|
2001-07-24 |
2005-08-10 |
Bristol Myers Squibb Co |
S-6-HYDROXY-BUSPIRONE
|
|
HUP0401403A3
(en)
|
2001-08-03 |
2005-11-28 |
Novo Nordisk As |
2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
CN101851173A
(zh)
|
2001-09-14 |
2010-10-06 |
梅特希尔基因公司 |
组蛋白脱乙酰化酶抑制剂
|
|
EP1295884A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
|
|
CA2457965C
(en)
|
2001-09-21 |
2010-06-01 |
Sanofi-Synthelabo |
Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
|
|
EP1295885A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
|
|
EA007165B1
(ru)
|
2001-09-21 |
2006-08-25 |
Санофи-Авентис |
Производные замещенного 2-пиримидинил-6, 7, 8, 9-тетрагидропиримидо [1,2-а]пиримидин-4-она и 7-пиримидинил-2,3-дигидроимидазо[1, 2-а]пиримидин-5( 1н )она для нейродегенеративных нарушений
|
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
|
CN1578781A
(zh)
|
2001-09-26 |
2005-02-09 |
拜尔药品公司 |
用作抗糖尿病药物的1,8－萘啶衍生物
|
|
US6951849B2
(en)
*
|
2001-10-02 |
2005-10-04 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
BR0213611A
(pt)
|
2001-10-02 |
2005-12-20 |
Acadia Pharm Inc |
Composto, composição farmacêutica, seus usos, método para aumentar a atividade de um receptor colinérgico, métodos para tratamento ou prevenção de distúrbio mental, dor, pressão intraocular aumentada e progressão ou formação de placas amilóides
|
|
WO2004089942A2
(en)
|
2001-10-02 |
2004-10-21 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
JP2005506339A
(ja)
*
|
2001-10-10 |
2005-03-03 |
シェーリング コーポレイション |
ムスカリン性アンタゴニストとしてのピペリジン化合物
|
|
US6924311B2
(en)
|
2001-10-17 |
2005-08-02 |
X-Ceptor Therapeutics, Inc. |
Methods for affecting various diseases utilizing LXR compounds
|
|
CN100548291C
(zh)
|
2001-10-25 |
2009-10-14 |
先灵公司 |
用于治疗肥胖的mch拮抗剂
|
|
IL161663A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3beta INHIBITORS
|
|
ES2294190T3
(es)
|
2001-11-01 |
2008-04-01 |
Janssen Pharmaceutica N.V. |
Derivados de amida como inhibidores de la glucogeno sintasa quinasa 3-beta.
|
|
HUP0402106A3
(en)
|
2001-11-01 |
2009-07-28 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
ES2289159T3
(es)
|
2001-11-14 |
2008-02-01 |
Ortho-Mcneil Pharmaceutical Corporation |
Derivados tetraciclicos sustituidos de pirroloquinolona utilizados como inhibidores de fosfodiesterasa.
|
|
GB0128287D0
(en)
|
2001-11-26 |
2002-01-16 |
Smithkline Beecham Plc |
Novel method and compounds
|
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
|
WO2003048137A1
(en)
|
2001-11-30 |
2003-06-12 |
Merck & Co., Inc. |
Metabotropic glutamate receptor-5 modulators
|
|
HU228316B1
(en)
|
2001-12-13 |
2013-03-28 |
Daiichi Sankyo Company |
Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
|
|
DE60222698T2
(de)
|
2001-12-18 |
2008-06-19 |
Merck & Co., Inc. |
Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5
|
|
DE60223720T2
(de)
|
2001-12-18 |
2008-10-30 |
Merck & Co., Inc. |
Heteroaryl-substituierte pyrazol-modulatoren des metabotropen glutamatrezeptors-5
|
|
WO2003053922A2
(en)
|
2001-12-19 |
2003-07-03 |
Merck & Co., Inc. |
Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
|
WO2003051847A1
(en)
|
2001-12-19 |
2003-06-26 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
|
SE0104341D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New use
|
|
TW200301123A
(en)
|
2001-12-21 |
2003-07-01 |
Astrazeneca Uk Ltd |
New use
|
|
EP1458711B1
(en)
|
2001-12-21 |
2007-07-18 |
AstraZeneca AB |
Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
|
|
EP1458710A4
(en)
|
2001-12-21 |
2005-04-20 |
Merck & Co Inc |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
|
DE10163991A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
|
KR20090031962A
(ko)
|
2001-12-27 |
2009-03-30 |
다이쇼 세이야꾸 가부시끼가이샤 |
6-플루오로비시클로[3.1.0]헥산 유도체
|
|
ES2251624T3
(es)
|
2001-12-28 |
2006-05-01 |
Acadia Pharmaceuticals Inc. |
Analogos de la tetrahidroquinolina como los agonistas muscarinicos.
|
|
US7550459B2
(en)
|
2001-12-28 |
2009-06-23 |
Acadia Pharmaceuticals, Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
WO2003057698A2
(en)
|
2001-12-28 |
2003-07-17 |
Acadia Pharmaceuticals, Inc. |
Spiroazacyclic compounds as monoamine receptor modulators
|
|
US6495700B1
(en)
|
2002-01-09 |
2002-12-17 |
Axonyx, Inc. |
Process for producing phenserine and its analog
|
|
DE10201550A1
(de)
*
|
2002-01-17 |
2003-07-31 |
Merck Patent Gmbh |
Phenoxy-Piperidine
|
|
TW200302726A
(en)
|
2002-01-31 |
2003-08-16 |
Ono Pharmaceutical Co |
Nitrogen-containing bicyclic compound and medicament containing same as active ingredient
|
|
MXPA04007737A
(es)
|
2002-02-11 |
2004-10-15 |
Pfizer |
Derivados de nicotinamida utiles como inhibidores de fosfodesterasas 4.
|
|
WO2003068773A1
(en)
|
2002-02-12 |
2003-08-21 |
Glaxo Group Limited |
Pyrazolopyridine derivatives
|
|
TW200306191A
(en)
|
2002-02-22 |
2003-11-16 |
Teijin Ltd |
Pyrrolopyrimidine derivatives
|
|
CA2477117A1
(en)
|
2002-02-22 |
2003-08-28 |
Teijin Limited |
Pyrrolopyrimidine derivative
|
|
DE60302221T2
(de)
|
2002-02-28 |
2006-08-03 |
Sanofi-Aventis |
Heteroaryl substituierte 2-pyridinyl und 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-onderivate
|
|
EP1340759A1
(en)
|
2002-02-28 |
2003-09-03 |
Sanofi-Synthelabo |
1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
|
|
WO2003076442A1
(en)
|
2002-03-05 |
2003-09-18 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
|
ES2289274T3
(es)
|
2002-03-08 |
2008-02-01 |
Eli Lilly And Company |
Derivados de pirrol-2,5-diona y su uso como inhibidores de gsk-3.
|
|
EP1483260A1
(de)
|
2002-03-11 |
2004-12-08 |
Schering Aktiengesellschaft |
Cdk inhibitorische 2-heteroaryl-pyrimidine, deren herstellung und verwendung als arzneimittel
|
|
EP1485093B1
(en)
|
2002-03-12 |
2010-11-03 |
Merck Sharp & Dohme Corp. |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
CN100445276C
(zh)
|
2002-03-13 |
2008-12-24 |
詹森药业有限公司 |
用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
|
|
CA2475766C
(en)
|
2002-03-13 |
2012-06-05 |
Janssen Pharmaceutica N.V. |
Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
|
|
EA007099B1
(ru)
|
2002-03-13 |
2006-06-30 |
Янссен Фармацевтика Н. В. |
Сульфонилпроизводные в качестве ингибиторов гистон-деацетилазы
|
|
MXPA04008797A
(es)
|
2002-03-13 |
2004-11-26 |
Janssen Pharmaceutica Nv |
Inhibidores de histona desacetilasa.
|
|
DE60220016T2
(de)
|
2002-03-20 |
2008-01-10 |
Société des Produits Nestlé S.A. |
Kakaoextrakt mit niedrigem Fettgehalt
|
|
GB0206723D0
(en)
|
2002-03-21 |
2002-05-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
|
GB0207246D0
(en)
|
2002-03-27 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0207249D0
(en)
|
2002-03-27 |
2002-05-08 |
Glaxo Group Ltd |
Novel compounds
|
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
|
SE0302546D0
(sv)
|
2003-09-24 |
2003-09-24 |
Astrazeneca Ab |
New compounds
|
|
TW200918046A
(en)
|
2002-04-03 |
2009-05-01 |
Novartis Ag |
Indolylmaleimide derivatives
|
|
NZ536116A
(en)
|
2002-04-03 |
2007-01-26 |
Topotarget Uk Ltd |
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
|
|
US6808075B2
(en)
*
|
2002-04-17 |
2004-10-26 |
Cytonome, Inc. |
Method and apparatus for sorting particles
|
|
SE0201194D0
(sv)
|
2002-04-19 |
2002-04-19 |
Astrazeneca Ab |
New compounds
|
|
CN1649845A
(zh)
*
|
2002-04-26 |
2005-08-03 |
先灵公司 |
蝇蕈碱拮抗剂
|
|
GB0210124D0
(en)
|
2002-05-02 |
2002-06-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2003095452A1
(en)
|
2002-05-08 |
2003-11-20 |
Janssen Pharmaceutica N.V. |
Substituted pyrroline kinase inhibitors
|
|
WO2004034963A2
(en)
|
2002-05-17 |
2004-04-29 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
GB0212048D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1513830A1
(en)
|
2002-06-05 |
2005-03-16 |
Janssen Pharmaceutica N.V. |
Bisindolyl-maleimid derivatives as kinase inhibitors
|
|
JP2005531607A
(ja)
|
2002-06-05 |
2005-10-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤として置換ピロリン
|
|
DE60317684T4
(de)
|
2002-06-19 |
2011-06-22 |
Janssen Pharmaceutica N.V., 2340 |
SUBSTITUIERTE 2,4-DIHYDROPYRROLOc3,4BÜCHINOLIN-9-ONDERIVATE, DIE SICH ALS PHOSPHODIESTERASEINHIBITOREN EIGNEN
|
|
EP2256108B1
(en)
|
2002-07-18 |
2016-03-23 |
Janssen Pharmaceutica NV |
Substituted triazine kinase inhibitors
|
|
AU2003256616B2
(en)
|
2002-07-19 |
2009-08-27 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
|
|
AU2003261204A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
|
AU2003254053A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
JP2006514918A
(ja)
|
2002-07-23 |
2006-05-18 |
スミスクライン ビーチャム コーポレーション |
キナーゼインヒビターとしてのピラゾロピリミジン
|
|
CN1319968C
(zh)
|
2002-08-02 |
2007-06-06 |
沃泰克斯药物股份有限公司 |
用作gsk－3的抑制剂的吡唑组合物
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
DE60335380D1
(de)
*
|
2002-08-22 |
2011-01-27 |
Lilly Co Eli |
Muskarine agonisten
|
|
DE60313872T2
(de)
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
MXPA05002571A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
EP1400244A1
(en)
|
2002-09-17 |
2004-03-24 |
Warner-Lambert Company LLC |
New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
|
|
WO2004032851A2
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Screening and therapeutic methods relating to neurogenesis
|
|
CN1717391A
(zh)
|
2002-10-21 |
2006-01-04 |
希龙公司 |
糖元合成酶激酶3的抑制剂
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
DK1583541T3
(da)
|
2002-11-20 |
2011-04-11 |
Neuronova Ab |
Forbindelser og fremgangsmåder til at øge neurogenese
|
|
US20040185429A1
(en)
|
2002-12-09 |
2004-09-23 |
Judith Kelleher-Andersson |
Method for discovering neurogenic agents
|
|
GB0229581D0
(en)
|
2002-12-19 |
2003-01-22 |
Cyclacel Ltd |
Use
|
|
KR100897642B1
(ko)
|
2002-12-20 |
2009-05-14 |
글락소 그룹 리미티드 |
신경 장애 치료용 벤즈아제핀 유도체
|
|
US7135493B2
(en)
|
2003-01-13 |
2006-11-14 |
Astellas Pharma Inc. |
HDAC inhibitor
|
|
KR100791252B1
(ko)
|
2003-01-23 |
2008-01-03 |
크리스탈지노믹스(주) |
글리코겐 합성효소 키나아제 3β 활성 억제제, 이의제조방법 및 이를 유효성분으로 함유하는 약학 조성물
|
|
JP2006515628A
(ja)
*
|
2003-01-23 |
2006-06-01 |
アカディア ファーマシューティカルズ，インコーポレーテッド |
ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用
|
|
WO2004069813A1
(en)
|
2003-01-31 |
2004-08-19 |
Astrazeneca Ab |
Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
|
|
US6969716B2
(en)
|
2003-02-07 |
2005-11-29 |
Merck Sharp & Dohme Ltd. |
5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression
|
|
JP2006518381A
(ja)
|
2003-02-07 |
2006-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール
|
|
GB0303319D0
(en)
|
2003-02-13 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
EP1454900A1
(en)
|
2003-03-07 |
2004-09-08 |
Sanofi-Synthelabo |
Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
|
|
EP1454908B1
(en)
|
2003-03-07 |
2008-02-27 |
Sanofi-Aventis |
Substituted pyridinyl-2-(diaza-bicyclo-alkyl)-pyrimidinone derivatives
|
|
EP1454910A1
(en)
|
2003-03-07 |
2004-09-08 |
Sanofi-Synthelabo |
Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
|
|
EP1454909B1
(en)
|
2003-03-07 |
2008-08-20 |
Sanofi Aventis |
8'-pyridinyl-dihydrospiro- (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro (cycloalkyl) -pyrimido (1,2-a) pyrimidin-6-one derivatives and their use against neurodegenerative diseases
|
|
TWI292318B
(en)
|
2003-03-10 |
2008-01-11 |
Hoffmann La Roche |
Imidazol-4-yl-ethynyl-pyridine derivatives
|
|
US7217712B2
(en)
|
2003-03-12 |
2007-05-15 |
Vertex Pharmaceuticals Incorporated |
4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors
|
|
US7381825B2
(en)
|
2003-03-17 |
2008-06-03 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
EP1460076A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
|
|
WO2004085395A1
(en)
*
|
2003-03-25 |
2004-10-07 |
Faust Pharmaceuticals |
Melatonin derivatives and their use for treating neurological dysfunctions
|
|
WO2004085439A1
(en)
|
2003-03-27 |
2004-10-07 |
Pfizer Products Inc. |
Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
|
|
NZ542690A
(en)
|
2003-03-28 |
2009-04-30 |
Acadia Pharm Inc |
Muscarinic M1 receptor agonists for pain management
|
|
JP2006522144A
(ja)
|
2003-04-04 |
2006-09-28 |
ダイノゲン ファーマシューティカルズ，インコーポレイテッド |
下部尿路障害の治療方法
|
|
SG169900A1
(en)
|
2003-04-16 |
2011-04-29 |
Memory Pharm Corp |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
|
US20040254152A1
(en)
|
2003-04-17 |
2004-12-16 |
Monje Michelle L. |
Prevention of deficits in neurogenesis with anti-inflammatory agents
|
|
CA2524161C
(en)
|
2003-05-08 |
2013-01-15 |
Applied Research Systems Ars Holding N.V. |
Pyridinyl acetonitriles
|
|
US20050090449A1
(en)
*
|
2003-05-13 |
2005-04-28 |
Boehringer Ingelheim International Gmbh |
Novel statine derivatives for the treatment of Alzheimer's disease
|
|
GB0311859D0
(en)
|
2003-05-22 |
2003-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
|
US7763588B2
(en)
|
2003-06-13 |
2010-07-27 |
The Salk Institute For Biological Studies |
Method for increasing cognitive function and neurogenesis
|
|
EP1654255B1
(en)
|
2003-06-13 |
2008-08-27 |
Janssen Pharmaceutica N.V. |
Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
|
|
ATE409480T1
(de)
|
2003-06-27 |
2008-10-15 |
Pfizer Prod Inc |
Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
|
|
EP1641455B1
(en)
*
|
2003-06-27 |
2008-08-06 |
Pfizer Products Inc. |
Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
|
AU2004260738B2
(en)
|
2003-07-16 |
2009-07-16 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
WO2005013961A1
(en)
*
|
2003-07-17 |
2005-02-17 |
Eli Lilly And Company |
Combination therapy for treatment of cognitive disorders or psychoses
|
|
CA2532965C
(en)
|
2003-07-22 |
2013-05-14 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
ES2293287T3
(es)
|
2003-07-25 |
2008-03-16 |
F. Hoffmann-La Roche Ag |
Combinacion de antagonista de mglur2 y de inhibidor de ache para el tratamiento de trastornos neurologicos agudos y/o cronicos.
|
|
JP2007500178A
(ja)
|
2003-07-30 |
2007-01-11 |
サイクラセル・リミテッド |
プロテインキナーゼ阻害剤としてのピリジニルアミノ−ピリミジン誘導体
|
|
EP1648875A1
(en)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
WO2005017189A2
(en)
|
2003-08-05 |
2005-02-24 |
University Of Florida Research Foundation, Inc. |
Neural cell assay
|
|
RU2358975C2
(ru)
|
2003-08-26 |
2009-06-20 |
Тейдзин Фарма Лимитед |
Пирролопиримидиноновые производные
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
DE602004010178T2
(de)
|
2003-09-12 |
2008-09-11 |
Laboratoires Serono S.A., Coinsins |
Benzothiazol-derivate zur behandlung von diabetes
|
|
JP2007505085A
(ja)
|
2003-09-12 |
2007-03-08 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
ベンゾイミダゾールアセトニトリル
|
|
AU2004272307A1
(en)
|
2003-09-12 |
2005-03-24 |
Merck Serono Sa |
Benzoxazole acetonitriles
|
|
RU2006115615A
(ru)
|
2003-10-10 |
2007-11-27 |
Марс, Инкорпорейтед (Us) |
Лечение заболеваний, в патогенез которых вовлечена гиперэкспрессия киназы erbb2
|
|
BRPI0415185A
(pt)
|
2003-10-10 |
2006-11-28 |
Pfizer Prod Inc |
2h-[1,2,4]triazol[4,3-a]pirazinas substituìdas como inibidores da gsk-3
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
JP5164380B2
(ja)
|
2003-10-21 |
2013-03-21 |
サイクラセル リミテッド |
ピリミジン−４−イル−３，４−チオン化合物及び治療におけるその使用
|
|
WO2005041979A1
(en)
*
|
2003-10-30 |
2005-05-12 |
University Of South Florida |
Modulation of microglial by nicotinic medications
|
|
US7671072B2
(en)
|
2003-11-26 |
2010-03-02 |
Pfizer Inc. |
Aminopyrazole derivatives as GSK-3 inhibitors
|
|
US7855195B2
(en)
|
2003-12-02 |
2010-12-21 |
Pharmaneuroboost N.V. |
Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
US20050137234A1
(en)
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
US20050159470A1
(en)
|
2003-12-19 |
2005-07-21 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
PT1696931E
(pt)
|
2003-12-22 |
2009-06-12 |
Acadia Pharm Inc |
Análogos diaril[a,d]ciclo-hepteno substituídos com amino utilizados como agonistas muscarínicos e métodos de tratamento de perturbações neuropsiquiátricas
|
|
WO2005072713A2
(en)
*
|
2004-01-27 |
2005-08-11 |
The Feinstein Institute For Medical Research |
Cholinesterase inhibitors for treating inflammation
|
|
CA2554140A1
(en)
|
2004-01-30 |
2005-08-18 |
Mars, Incorporated |
Methods and compositions for treating cancer
|
|
TWI301760B
(en)
|
2004-02-27 |
2008-10-11 |
Merz Pharma Gmbh & Co Kgaa |
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
|
|
US7705017B2
(en)
|
2004-05-03 |
2010-04-27 |
En Vivo Pharmaceuticals, Inc. |
Compounds for treatment of neurodegenerative diseases
|
|
GB0428170D0
(en)
*
|
2004-12-23 |
2005-01-26 |
Biopartners Ltd |
Mono and Combination Therapy
|
|
GB0428180D0
(en)
*
|
2004-12-23 |
2005-01-26 |
Biopartners Ltd |
Combination therapy
|
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|